291
Views
0
CrossRef citations to date
0
Altmetric
Original

Expectations and Implications of Blood Sparing with Hemoglobin Based Oxygen Carriers

Pages 93-105 | Published online: 24 Aug 2009

REFERENCES

  • Fratantoni, J.C. (1994). Points to consider on efficacy evaluation of hemoglobin- and perflurocarbon-based oxygen carriers. Transfusion 34: 712–713.
  • Stehling, L.C., Doherty, D.C., Faust, R.J. (1996). Practice guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 84: 732–747.
  • Levy, J.H., Goodnough, L.T., Grelich, P.E., Parr, G.V.S., Stewart, R.W., Gratz, I., Wahr, J., Williams, J., Comunale, M.E., Doblar, D., Silvay, G., Cohen, M., Jahr, J.S., Vlahakes, G.J. (2002). Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell tranfusion after cardiac surgery: Results of a randomized, double-blinded trial. J. Thorac. Cardiovasc. Surg. 124: 35–42.
  • Jahr, J.S. (2002). A Novel Blood Substitute: Use of HBOC-201 (Hemopure®) to Decrease Need for RBCs: Results of Pivotal Trial in Orthopedic Surgery Patients, paper presentation to Society of Critical Care Medicine meeting, San Diego, CA.
  • Lamy, M.L., Daily, E.K., Brichant, J.-F., Larbuisson, R.P., Demeyere, R.H., Vandermeersch, E.A., Lehot, J.-J., Parsloe, M.R., Berridge, J.C., Sinclair, C.J., Baron, J.-F., Przybelski, R.J. (2000). Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. The DCLHb Cardiac Surgery Trial Collaborative Group. Anesthesiology 92: 646–656.
  • Schubert, A., Przybelski, R.J., Eidt, J.F., Lasky, L.C., Marks, K.E., Karafa, M., Novick, A.C., O'Hara, J.F. Jr., Saunders, M.E., Blue, J.W., Tetzlaff, J.E., Mascha, E. (2003). Diaspirin-crosslinked hemoglobin reduces blood transfusion in noncardiac surgery: A multicenter, randomized, controlled, double-blinded trial. Anesth. Analg. 97(2): 323–332.
  • Lee, R., Neya, K., Svizzero, T.A., Vlahakes, G.J. (1995). Limitations of the efficacy of hemoglobin-basaed oxygen-carrying solutions. J. Appl. Physiol. 79(1): 236–242.
  • DeVenuto, F., Friedman, H.I., Neville, J.R., Peck, C.C. (1979). Appraisal of hemoglobin as a blood substitute. Surg. Gynecol. Obstet. 149: 417–436.
  • Bleeker, W.K., van der Plas, J., Feitsma, R.I.J., Agterberg, J., Rigter, G., de Vries-van Rossen, A., Pauwels, E.K.J., Bakker, J.C. (1989). In vivo distribution and elimination of hemoglobin modified by intramolecular cross-linking with 2-nor-formylpyridoxal 5′-phosphate. J. Lab. Clin. Med. 113: 151–161.
  • Lenz, G., Junger, H., Schneider, M., Kothe, N., Lissner, R., Prince, A. (1991). Elimination of pyridoxylated polyhemoglobin after partial exchange transfusion in chimpanzees. Biomat. Art Cells Immob. Biotech. 19(4): 699–708.
  • Boswell, G., Rodkey, W.G. (1983). Pharmacokinetics of hemoglobin infusion. Progr. Clin. Biol. Res. 122: 139–147.
  • Migita, R., Gonzales, A., Gonzales, M.L., Vandegriff, K.D., Winslow, R.M. (1997). Blood volume and cardiac index in rate after exchange transfusion with hemoglobin-based oxygen carriers. J. Appl. Physiol. 82(5): 1995–2002.
  • Wicks, D., Wong, L.T., Sandhu, R., Stewart, R.K., Biro, G.P. (2003). The intravascular persistance and methemoglobin formation of Hemolink (hemoglobin raffimer) in dogs. Art. Cells Blood Substit. Biotechnol. 31: 1–17.
  • Pearce, L.B., Rentko, V.T., Moon-Massat, P.F., Gawryl, M.S. (2003). Comparative pharmacokinetics of a hemoglobin-based oxygen carrier. Academic Emergency Medicine 10(5): 557–558.
  • O'Hara, J.F., Colburn, W.A., Tetzlaff, J.E., Novick, A.C., Angermeier, K.W., Schubert, A. (2001). Hemoglobin and methemoglobin concentrations after large-dose infusions of diasprin cross-linked hemoglobin. Anesth. Analg. 92: 44–48.
  • Hughes, G.S., Antal, E.J., Locker, P.K., Francom, S.F., Adams, W.J., Jacobs, E.E. (1996). Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans. Crit. Care Med. 24: 756–764.
  • Goodnough, L.T., Skikne, B., Brugnara, C. (2000). Erythropoietin, iron, and erythropoiesis. Blood 96(3): 823–833.
  • Van der Linden, P. (1998). Anemic hypoxia, in Tissue Oxygenation in Acute Medicine, W.J. Sibbald, K. Messmer, M.P. Fink, Eds., Springer: New York, pp. 116–127.
  • Posner, L.P., Moon, P.F., Bliss, S.P., Gleed, R.D., Erb, H.N. (2003). Colloid osmotic pressure after hemorrhage and replenishment with Oxyglobin solution, hetastarch, or whole blood in pregnant sheep. Vet. Anaesth. Analg. 30: 30–36.
  • Fischer, S.R., Burnet, M., Traber, D.L., Prough, D.S., Kramer, G.C. (1999). Plasma volume expansion with solutions of hemoglobin, albumin, and Ringer lactate in sheep. Am. J. Physiol. 276 ( Heart Circ. Physiol., 45): H2194–H2203.
  • Vane, L.A., Funston, J.S., Kirschner, D.H., Harpter, D., Deyo, D.J., Traber, D.L., Traber, L.L., Kramer, G.C. (2002). Comparison of tranfusion with DCLHb or pRBCs for treatment of intraoperative anemia in sheep. J. Appl. Physiol. 92: 343–353.
  • Standl, T., Horn, P., Wilhelm, S., Greim, C., Freitag, M., Freitag, U., Sputtek, A., Jacobs, E., am Esch, J.S. (1996). Bovine haemoglobin is more potent than autologous red blood cells in restoring muscular tissue oxygenation after profound isovolaemic haemodilution in dogs. Can. J. Anaesth. 43(7): 714–723.
  • Wedgewood, J.J., Thomas, J.G. (1996). Peri-operative haemoglobin: An overview of current opinion regarding the acceptable level of haemoglobin in the peri-operative period. Eur. J. Anaesthesiol. 13: 316–324.
  • Goodnough, L.T., Despotis, G.J., Hogue, C.W., Fergueson, T.B. (1995). On the need for improved transfusion indicators in cardiac surgery. Ann. Thorac. Surg. 60: 473–480.
  • Herbert, P.C., Wells, G., Blajchman, M.A., Marshall, J., Martin, C., Pagliarello, G., Tweeddale, M., Schweitzer, I., Yetsir, E. (1999). A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canandian Critical Care Trials Group. New Engl. J. Med. 340: 409–417.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.